基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
IVANA D. LUKIĆ
Date of birth: April 22th, 1984
Address:
Office Institute of Virology, Vaccine and Sera "Torlak" (The Immunochemistry Department), Vojvode Stepe 458, 11152 Belgrade, Serbia
e-mail ilukic@torlak.rs
anavimasaj@gmail.com
phone: +381 63 8163 930
ORCID: 0000-0002-6330-471X
EDUCATION
2018 PhD in Biochemistry, Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Republic of Serbia, Ph.D. 2011-2018.
PhD Thesis Title: “Therapeutic potential of anti-tetanus toxoid monoclonal antibodies: application based on binding properties”.
2011 MSc in Biochemistry, Department of Biochemistry, Faculty of Chemistry, University of Belgrade, MSc 2010-2011. Title of defended thesis: “Purification of tetanus toxoid: chromatographic techniques as an alternative to ammonium sulfate precipitation”
2010 BSc in Biochemistry, Department of Biochemistry, Faculty of Chemistry, University of Belgrade, BSc 2003 – 2010;
PROFESSIONAL EXPERIENCE
2021 – present Head of the Immunochemistry department
The Immunochemistry Department, Institute of Virology, Vaccine and Sera "Torlak", Belgrade, Serbia.
2018 - present Research Associate
Department of Research and Development, Institute of Virology, Vaccine and Sera "Torlak", Belgrade, Serbia.
2019 - 2021 Associate on Department of Immunochemistry
Department of Immunochemistry, Institute of Virology, Vaccine and Sera "Torlak", Belgrade, Serbia.
2012 - 2018 Research Assistant
Department of Research and Development, Institute of Virology, Vaccine and Sera "Torlak", Belgrade, Serbia.
2010 - 2012 Research Trainee
Department of Research and Development, Institute of Virology, Vaccine and Sera "Torlak", Belgrade, Serbia.
WORK EXPERIENCE
Production of Active Pharmaceutical IngredientsActive Pharmaceutical Ingredients of bacterial vaccines:
• BCG vaccine freeze-dried
• Tetavaksal-T® - tetanus vaccine, adsorbed
• Ditevaksal-T ® - diphtheria and tetanus vaccine, adsorbed
• Ditevaksal-T ® - diphtheria and tetanus vaccine for adults, adsorbed
• Aldipete-T® - diphtheria, tetanus and pertussis vaccine, adsorbed
Production of of sera:
• Totekvin® - tetanus antitoxin (equine) for human use
• Viekvin® - viper venom antiserum (equine)
Production of Immunodiagnostics
• Tuberculin PPD-T®
Other
• Participation in planning of a process of upgrade the existing production facilities for the production of antiviperin sera - VIEKVIN® and other vaccines, in accordance to the principles of Good Manufacture Practice - GMP for parenteral medicinal products.
• Participation in Public Procurement of good needed in production processes
RESEARCH EXPERIENCE
• Purification and characterization of monoclonal antibodies
• Protein purification and quantification of proteins
• Animal model of human disease (mouse model of inflammatory bowel disease, guinea pig model of ocular infection)
• In vitro cell culturing
• Immunochemical techniques (ELISA, ELISpot, Western blot)
• Immunofluorescent based techniques (Flow cytometry, confocal microscopy)
PROJECT PARTICIPATION
National projects
2012- 2019 Allergens, antibodies, enzymes and physiological active molecules: design, structure, function and significance (Supported by Ministry of Education and Science, Republic of Serbia, Grant No 172049).
2019-2021 Project PoC ID 5132 ”Novel treatment approach for tetanus toxin intoxication” (Supported by Ministry of Education and Science and Innovation Fond, Republic of Serbia,
International projects
2016-2017 Bilateral project between Serbia and Austria “Impact of Different Genetic Mouse Background on the Immune Response after Conjunctival Immunization with Chlamydial Polymorphic Membrane Protein C expressed within E.coli Nissle 1917 Bacterial Ghosts“, project co-financed by the Ministry of Education, Science and Technological Development of the Republic of Serbia, the program of bilateral scientific and technical cooperation of the Republic of Austria and the Republic of Serbia 2016-2017., project no. 451-03-01039/2015-09/04
2011-2018 FFG project OCUVAC project: Ocular Chlamydia trachomatis vaccine development”, project funded by the Austrian Ministry of Economy, the program Laura Bassi Centers of Expertise, FFG project no. 822768 (project carrier Institute of Specific Prophylaxis and Tropical Medicine, The Centre for Pathophysiology, Infectology and Immunology, Medical University Vienna, Austrija; with Cooperation Agreement between Institute „Torlak“ and Institute of Specific Prophylaxis and Tropical Medicine).
SHORT-TERM RESEARCH FELLOWSHIPS
2015 Visiting researcher, laboratory of Prof. Dr. Talin Barisani-Asenbauer, Centres of Expertise Laura Bassi, Medizinische Universität Wien, Vienna, Austria
EDUCATIONAL COURSES AND WORKSHOPS
2016 Specific Prophylaxis and Tropical Medicine, The Centre for Pathophysiology, Infectology and Immunology, Medical University Vienna
Research Interests
Papers共 15 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nutrientsno. 11 (2024): 1705
A. Inic-Kanada,I. Lukic, E. Marinkovic, A. Filipovic, R. Miljkovic,T. Barisani-Asenbauer,U. Wiedermann,M. Stojanovic
Cited0Views0Bibtex
0
0
PloS oneno. 2 (2017): e0172469-e0172469
Cited22Views0Bibtex
22
0
Cited23Views0Bibtex
23
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn